Cysteine and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cysteine (n - acetyl cysteine) and Abilify (aripiprazole). Common drug interactions include serotonin syndrome among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Cysteine and Abilify. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Cysteine?

Cysteine has active ingredients of n - acetyl cysteine. eHealthMe is studying from 1,755 Cysteine users. Check the latest studies of Cysteine.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

On Jul, 26, 2026

21 people who take Cysteine and Abilify together, and have interactions are studied.

What are the common drug interactions of Cysteine and Abilify, by gender? *:

female:

Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
Dizziness
Hyperhidrosis (abnormally increased sweating)
Affective disorder (mental disorder)
Breast mass
Diarrhoea
Infection
Malaise (a feeling of general discomfort or uneasiness)
Sinusitis (inflammation of sinus)
Syncope (loss of consciousness with an inability to maintain postural tone)

male:

Anxiety
Drug ineffective
Arthralgia (joint pain)
Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
Ascites (accumulation of fluid in the abdominal cavity)
Erosive duodenitis (a condition that affects the wall of the small intestine)
Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
Gastritis (inflammation of stomach)
Gastroenteritis (inflammation of stomach and intestine)
Haematochezia (passage of stools containing blood)

What are the common drug interactions of Cysteine and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Breast mass
Diarrhoea
Dizziness
Hyperhidrosis (abnormally increased sweating)
Malaise (a feeling of general discomfort or uneasiness)
Sinusitis (inflammation of sinus)
Injection site pain
Weight increased

30-39:

Drug ineffective
Live birth
Mania (a state of abnormally elevated or irritable mood)
Maternal exposure during pregnancy (use of substance during pregnancy)
Abdominal pain
Anastomotic haemorrhage (bleeding from surgical connection between two structures)
Arthralgia (joint pain)
Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
Ascites (accumulation of fluid in the abdominal cavity)
Erosive duodenitis (a condition that affects the wall of the small intestine)

40-49:

Dizziness
Faecal volume increased
Fear
Flatulence (flatus expelled through the anus)
Headache (pain in head)
Hyperhidrosis (abnormally increased sweating)
Nausea (feeling of having an urge to vomit)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Respiration (transport of oxygen from the outside air to the cells within tissues)
Syncope (loss of consciousness with an inability to maintain postural tone)

50-59:

Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)

60+:

Balance disorder
Hypoaesthesia (reduced sense of touch or sensation)
Knee arthroplasty
Pain in extremity
Spinal cord compression
Weight decreased

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 38.10%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 28.57%
Drowsiness: 3 people, 14.29%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 3 people, 14.29%
Pain: 2 people, 9.52%
Mania (a state of abnormally elevated or irritable mood): 2 people, 9.52%
Hypersensitivity: 2 people, 9.52%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 9.52%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 9.52%
Drug Hypersensitivity: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Cysteine and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously